Literature DB >> 28656478

Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis.

Talita Siara Almeida Baptista1, Laura Esteves Petersen1, Julia K Molina2, Tatiana de Nardi2, Andréa Wieck1, Aline do Prado3, Deise Marcela Piovesan3, Mauro Keisermann3, Rodrigo Grassi-Oliveira2, Moisés Evandro Bauer4,5.   

Abstract

Rheumatoid arthritis (RA) has been associated with cognitive impairment and peripheral production of autoantibodies. Autoantibodies against central nervous system (CNS) proteins and S100 calcium-binding β (S100β) were found increased in diseases characterized by cognitive impairment like Alzheimer disease and Neuropsychiatric Systemic Lupus Erythematosus (NPSLE). The aim of this study was to investigate the plasma levels of autoantibodies against myelin basic protein (anti-MBP), myelin oligodendrocyte glycoprotein (anti-MOG) and S100β, and their relationships with cognitive performance in RA patients. Twenty patients with active rheumatoid arthritis and 19 age-, sex-, and schooling-matched healthy controls were recruited. Multiple dimensions of cognitive function were evaluated by structured clinical questionnaires. Autoantibodies and S100β levels were assessed by ELISAs. Patients had significantly higher levels of anti-MBP IgG (17.51 ± 1.36 vs. 5.24 ± 0.53 ng/mL), anti-MOG IgG (5.68 ± 1.34 vs. 0.51 ± 0.49 ng/mL), and S100β protein (2.24 ± 0.50 vs. 0.47 ± 0.06) than controls (all p < 0.0001). After adjusting for potential confounders, RA group presented worse cognitive performance involving the working memory and executive functions such as inhibition, flexibility, and mental control in parallel to higher autoantibodies and S100β levels than healthy controls (all p < 0.001). Levels of anti-MBP were negatively associated with delayed verbal recall (DVR; r = -0.42, p = 0.005), Stroop Color-Word (r = -0.48, p = 0.004), and N-Back Total scores (r = -0.59, p < 0.0001) and positively with Trail Making Test B (TMB, r = 0.53, p = 0.001). Negative correlation was found between levels of anti-MOG and DVR (r = -0.64, p < 0.0001), N-Back Total scores (r = -0.35, p = 0.03), Stroop Color-Word (r = -0.51, p = 0.001), and positively with TMB (r = 0.50, p = 0.003). S100β levels were associated with DVR (r = -0.51, p = 0.002), TMB (r = 0.46, p = 0.008), Stroop Color-Word (r = -0.67, p < 0.0001), and N-Back Total (r = -0.52, p = 0.003). RA is associated with impaired cognitive performance associated with higher levels of CNS-related autoantibodies and S100β levels. Given the importance of myelin integrity to cognition, our data indicate that these autoantibodies may be harmful to proper cognitive function.

Entities:  

Keywords:  Autoantibodies; Cognitive dysfunction; Myelin sheath; Rheumatoid arthritis; S100β

Mesh:

Substances:

Year:  2017        PMID: 28656478     DOI: 10.1007/s10067-017-3724-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  49 in total

Review 1.  Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases.

Authors:  D S Domiciano; J F Carvalho; Y Shoenfeld
Journal:  Lupus       Date:  2009-11       Impact factor: 2.911

Review 2.  Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice.

Authors:  Jaclyn Anderson; Liron Caplan; Jinoos Yazdany; Mark L Robbins; Tuhina Neogi; Kaleb Michaud; Kenneth G Saag; James R O'Dell; Salahuddin Kazi
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

Review 3.  An Integrative Review of Correlates and Predictors of Depression in Patients with Rheumatoid Arthritis.

Authors:  Monica Iaquinta; Susan McCrone
Journal:  Arch Psychiatr Nurs       Date:  2015-04-20       Impact factor: 2.218

4.  Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis.

Authors:  Sherifa A Hamed; Zahra I Selim; Amal M Elattar; Yasser M Elserogy; Eman A Ahmed; Hanan O Mohamed
Journal:  Clin Rheumatol       Date:  2011-06-22       Impact factor: 2.980

5.  Glucocorticoid therapy-induced memory deficits: acute versus chronic effects.

Authors:  Daniel Coluccia; Oliver T Wolf; Spyros Kollias; Benno Roozendaal; Adrian Forster; Dominique J-F de Quervain
Journal:  J Neurosci       Date:  2008-03-26       Impact factor: 6.167

6.  Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men.

Authors:  Po H Lu; Grace J Lee; Todd A Tishler; Michael Meghpara; Paul M Thompson; George Bartzokis
Journal:  Brain Cogn       Date:  2012-11-27       Impact factor: 2.310

Review 7.  The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury?

Authors:  Elizabeth Perry; Clive Kelly; Paul Eggleton; Anthony De Soyza; David Hutchinson
Journal:  Rheumatology (Oxford)       Date:  2014-05-15       Impact factor: 7.580

Review 8.  Noninvasive molecular imaging of neuroinflammation.

Authors:  Andreas H Jacobs; Bertrand Tavitian
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-02       Impact factor: 6.200

9.  Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis--a genome-wide study combined with immunological analyses.

Authors:  Chikashi Terao; Koichiro Ohmura; Masaki Katayama; Meiko Takahashi; Miki Kokubo; Gora Diop; Yoshinobu Toda; Natsuki Yamamoto; Reiko Shinkura; Masakazu Shimizu; Ivo Gut; Simon Heath; Inga Melchers; Toshiaki Manabe; Mark Lathrop; Tsuneyo Mimori; Ryo Yamada; Fumihiko Matsuda
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

Review 10.  Inflammatory Response in the CNS: Friend or Foe?

Authors:  Marta Sochocka; Breno Satler Diniz; Jerzy Leszek
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

View more
  10 in total

Review 1.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

2.  Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors.

Authors:  Laura E Petersen; Talita S A Baptista; Júlia K Molina; Julia G Motta; Aline do Prado; Deise M Piovesan; Tatiana de Nardi; Thiago W Viola; Érica L M Vieira; Antonio L Teixeira; Rodrigo Grassi-Oliveira; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2018-01-25       Impact factor: 2.980

3.  Anti-Myelin Proteolipid Protein Peptide Monoclonal Antibodies Recognize Cell Surface Proteins on Developing Neurons and Inhibit Their Differentiation.

Authors:  Raymond A Sobel; Mary Jane Eaton; Prajakta Dilip Jaju; Eugene Lowry; Julian R Hinojoza
Journal:  J Neuropathol Exp Neurol       Date:  2019-09-01       Impact factor: 3.685

Review 4.  Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms.

Authors:  Maria Sofia Basile; Rosella Ciurleo; Alessia Bramanti; Maria Cristina Petralia; Paolo Fagone; Ferdinando Nicoletti; Eugenio Cavalli
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

5.  The Cerebral Brain-Derived Neurotrophic Factor Pathway, Either Neuronal or Endothelial, Is Impaired in Rats with Adjuvant-Induced Arthritis. Connection with Endothelial Dysfunction.

Authors:  Martin Pedard; Aurore Quirié; Philippe Garnier; Anne Tessier; Céline Demougeot; Christine Marie
Journal:  Front Physiol       Date:  2018-01-09       Impact factor: 4.566

Review 6.  Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder.

Authors:  Rut Mazón-Cabrera; Patrick Vandormael; Veerle Somers
Journal:  Front Immunol       Date:  2019-07-19       Impact factor: 7.561

Review 7.  Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression.

Authors:  Moisés E Bauer
Journal:  Immun Ageing       Date:  2020-03-09       Impact factor: 6.400

Review 8.  The interplay between immunosenescence and age-related diseases.

Authors:  Florencia Barbé-Tuana; Giselle Funchal; Carine Raquel Richter Schmitz; Rafael Moura Maurmann; Moisés E Bauer
Journal:  Semin Immunopathol       Date:  2020-08-03       Impact factor: 9.623

9.  Correlation of Serum BACE1 With Emergence Delirium in Postoperative Patients: A Preliminary Study.

Authors:  Chunyan Ye; Yanrong Zhang; Sumei Luo; Yanan Cao; Feng Gao; E Wang
Journal:  Front Aging Neurosci       Date:  2020-10-28       Impact factor: 5.750

10.  Reduced cognitive ability in people with rheumatoid arthritis compared with age-matched healthy controls.

Authors:  James M Gwinnutt; Task Toyoda; Stephen Jeffs; Emma Flanagan; Jacqueline R Chipping; Jack R Dainty; Eneida Mioshi; Michael Hornberger; Alex MacGregor
Journal:  Rheumatol Adv Pract       Date:  2021-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.